Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC
Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC
Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk BCR after radical RP
Enfortumab vedotin in combination with pembrolizumab is a potential new standard of care for 1L la/mUC
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC
Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma
Cancer personomics: Launching the missile - Localised endometrial carcinoma.
Novel therapies and combinations in ovarian cancer
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects
Colorectal cancer risk factors in Nigeria
Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy
The genomics of cancer in Africa
DNA methylation profile of prostate cancer aggressiveness in Ghana